Clinical Chemistry
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Clinical Chemistry 45: 685-688, 1999;
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (10)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Camps, J.
Right arrow Articles by Joven, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Camps, J.
Right arrow Articles by Joven, J.
Related Collections
Right arrow Proteomics and Protein Markers
Right arrow Endocrinology and Metabolism
(Clinical Chemistry. 1999;45:685-688.)
© 1999 American Association for Clinical Chemistry, Inc.


Technical Briefs

Altered Composition of Lipoproteins in Liver Cirrhosis Compromises Three Homogeneous Methods for HDL-Cholesterol

Jordi Campsa, Josep Ma Simó, Sandra Guaita, Natàlia Ferré and Jorge Joven

a address correspondence to this author at: C/.Sant Joan s/n, 43201-Reus, Catalunya, Spain

Despite the obvious clinical advantages, the measurement of HDL-cholesterol (HDL-C) by reliable and easy-to-perform methods is not yet completely free of problems. Several reports have described homogeneous (direct) assays for HDL-C that are readily adaptable to automated analyzers as online procedures (1)(2)(3). These methods have proved to be effective and inexpensive tools for the routine screening of HDL-C in large populations. However, in a recent article (4) we observed that one of these techniques significantly undervalued the concentrations of HDL-C in patients with liver cirrhosis, a condition in which alterations in lipoprotein structure and composition are commonly found (5). Although HDL-C is not a clinically important determination in liver cirrhosis, our finding may have consequences for research groups investigating lipoprotein metabolism and its alterations.

The aims of the present study were (a) to compare three different techniques for homogeneous HDL-C measurement with a reference method [single vertical-spin ultracentrifugation (SVS)] in a group of patients with cirrhosis; and (b) to investigate whether there was a relationship between the method biases and abnormal composition of lipoproteins.

The study was performed on 58 control subjects and 37 patients with liver cirrhosis. Control subjects were chosen randomly from the routine health and safety-at-work checks conducted in several industrial companies in our area. Excluded were those subjects with clinical or laboratory evidence of diabetes, neoplasia, renal disease, hepatic damage, and cardiovascular disease. Cirrhotic patients were diagnosed by liver biopsy and proceeded from the outpatient clinics of the Hospital Universitari de Sant Joan de Reus. The etiology of cirrhosis was alcoholic in 23 patients (62%), viral in 12 (32%), and cryptogenic in 2 (6%). Twelve of the 23 alcoholic cirrhotic patients had quit alcohol consumption at least 3 months prior to . . . [Full Text of this Article]


Acknowledgments


Footnotes


References




The following articles in journals at HighWire Press have cited this article:


Home page
Clin. Chem.Home page
F. Gomez, J. Camps, J. M. Simo, N. Ferre, and J. Joven
Agreement Study of Methods Based on the Elimination Principle for the Measurement of LDL- and HDL-Cholesterol Compared with Ultracentrifugation in Patients with Liver Cirrhosis
Clin. Chem., August 1, 2000; 46(8): 1188 - 1191.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1999 by the American Association for Clinical Chemistry.